Skip to content

The Use of Magnetic Brain Stimulation to Treat Obsessive Compulsive Disorder, a Pilot Study

The Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive Disorder (OCD), a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02541812
Enrollment
20
Registered
2015-09-04
Start date
2011-07-31
Completion date
2015-06-30
Last updated
2020-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

Obsessive-Compulsive Disorder, Transcranial Magnetic Stimulation, Error processing

Brief summary

The purpose of this study is two-fold: first, to observe the effect of one session of repetitive transcranial magnetic stimulation (rTMS) on the error-prediction abilities of patients with obsessive compulsive disorder (OCD) as well as healthy individuals; and second, to observe the clinical effect of 10 sessions of rTMS in patients with OCD.

Detailed description

A battery of cognitive tasks designed to selectively measure several aspects of anterior cingulate cortex (ACC) function, will be administered before and after one session of rTMS in all participants. The first neurocognitive session will be administered in a separate day from the rTMS session. The second neurocognitive session will be performed immediately after rTMS and in the same day. Participants will perform five tasks designed to test: error processing, error likelihood assessment, meta-memory, response inhibition, and affect recognition. The rTMS paradigm will consist of four short trains of magnetic pulses which include 5 minutes of stimulation with 1Hz frequency (overall 1200 pulses in one session) with an intensity of 110% of each participant's motor threshold, and 2 minute intervals between the stimulation trains. Stimulation will be applied over the dorsal ACC (dACC) using a double-cone rTMS coil. dACC will be precisely targeted using neuronavigation software loaded a high resolution MRI of each subjects' brain. OCD patients will go on to receive two weeks (10 sessions) of daily rTMS treatments using the same protocol described above.

Interventions

DEVICETranscranial Magnetic Stimulation

A non-invasive method for brain stimulation

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed obsessive compulsive disorder * Not currently receiving cognitive behavioural therapy * Not currently on any medication or only taking one selective serotonin reuptake inhibitor (SSRI)

Exclusion criteria

* History of psychotic episodes * History of neurological illness * Previous head injury * Active alcohol or substance abuse * History of seizure disorders * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Change in Obsessive and Compulsive Symptom Severity (Yale-Brown Obsessive Compulsive Scale)Recordings: baseline; after two weeks of rTMSYale-Brown Obsessive Compulsive Scale. Minimum value = 0. Maximum value = 40. Higher scores indicate greater severity of obsessive and compulsive symptoms.

Secondary

MeasureTime frameDescription
Change in Post-error SlowingRecordings: baseline; after one session of rTMSPost-error slowing (PES) is the difference in response time on trials following an error to trials following a correct response. Higher numbers indicate more post-error slowing (i.e. longer response times following an error trial compared to following a correct trial). The outcome measure is the change in PES from baseline to following one session of rTMS.

Participant flow

Participants by arm

ArmCount
Patients
Ten sessions of 1Hz repetitive Transcranial Magnetic Stimulation of the dorsal anterior cingulate cortex in patients with obsessive compulsive disorder Transcranial Magnetic Stimulation: A non-invasive method for brain stimulation
10
Healthy Control Subjects
One session of 1Hz repetitive Transcranial Magnetic Stimulation of the dorsal anterior cingulate cortex in healthy control individuals Transcranial Magnetic Stimulation: A non-invasive method for brain stimulation
10
Total20

Baseline characteristics

CharacteristicHealthy Control SubjectsTotalPatients
Age, Continuous29.5 years
STANDARD_DEVIATION 12.1
29.2 years
STANDARD_DEVIATION 12.1
28.7 years
STANDARD_DEVIATION 12.1
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Canada
10 participants20 participants10 participants
Sex: Female, Male
Female
4 Participants12 Participants8 Participants
Sex: Female, Male
Male
6 Participants8 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Change in Obsessive and Compulsive Symptom Severity (Yale-Brown Obsessive Compulsive Scale)

Yale-Brown Obsessive Compulsive Scale. Minimum value = 0. Maximum value = 40. Higher scores indicate greater severity of obsessive and compulsive symptoms.

Time frame: Recordings: baseline; after two weeks of rTMS

ArmMeasureValue (MEAN)Dispersion
PatientsChange in Obsessive and Compulsive Symptom Severity (Yale-Brown Obsessive Compulsive Scale)-39.4 Percent changeStandard Deviation 15.4
Secondary

Change in Post-error Slowing

Post-error slowing (PES) is the difference in response time on trials following an error to trials following a correct response. Higher numbers indicate more post-error slowing (i.e. longer response times following an error trial compared to following a correct trial). The outcome measure is the change in PES from baseline to following one session of rTMS.

Time frame: Recordings: baseline; after one session of rTMS

ArmMeasureValue (MEAN)Dispersion
PatientsChange in Post-error Slowing1.4 msStandard Deviation 5.8
Healthy Control SubjectsChange in Post-error Slowing-3.0 msStandard Deviation 4.8

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026